 The primary goal of this study is to assess the analgesic effect of DIclofenac 0.1 Eye Drops a topical NSAID, as well as a combination of Diclofenac 0.1 Eye Drops and oral Diclofenac Sodium sustained-release SR 75mg tablets on pain related to intravitreal injections immediately after and up to six hours post-IVI. 